Showing results (1-10 of 221) with videos related to
Sort By:
Pageof 23
Scientific Reports|September 2, 2023
Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort studyAlexander Winkelmann, Christoph Metze, Uwe K Zettl, et al.Neurology(R) Neuroimmunology & Neuroinflammation|January 11, 2020
Tick-borne encephalitis vaccination in multiple sclerosis: A prospective, multicenter studyAlexander Winkelmann, Christoph Metze, Silvius Frimmel, et al.Nature Reviews. Neurology|April 7, 2022
Vaccination and immunotherapies in neuroimmunological diseasesAlexander Winkelmann, Micha Loebermann, Michael Barnett, et al.Nature Reviews. Neurology|March 5, 2016
Disease-modifying therapies and infectious risks in multiple sclerosisAlexander Winkelmann, Micha Loebermann, Emil C Reisinger, et al.Nature Reviews. Neurology|January 25, 2012
Vaccination against infection in patients with multiple sclerosisMicha Loebermann, Alexander Winkelmann, Hans-Peter Hartung, et al.Frontiers in Immunology|August 24, 2019
Vaccination in Multiple Sclerosis: Friend or Foe?Tobias Zrzavy, Herwig Kollaritsch, Paulus S Rommer, et al.CNS Neuroscience & Therapeutics|July 26, 2018
Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapiesChristoph Metze, Alexander Winkelmann, Micha Loebermann, et al.Current Pharmaceutical Design|May 23, 2012
Use of intravenous immunoglobulin in the treatment of immune-mediated demyelinating diseases of the nervous systemAlexander Winkelmann, Uwe K ZettlDer Nervenarzt|September 19, 2019
[Indications for varicella zoster and herpes zoster vaccination in multiple sclerosis: current situation]Alexander Winkelmann, Micha Löbermann, Uwe K ZettlJournal of Neurology|May 16, 2007
Cognitive impairment in multiple sclerosisAlexander Winkelmann, Claudia Engel, Annett Apel, et al.Pageof 23